Table 2.
Compound | R | GLS IC50 (nM)a |
A549 IC50 (nM)b |
Microsomal Stability (mL/min/kg)c |
pH 7.4 Solubility (μM)d |
|
---|---|---|---|---|---|---|
Human | Rat | |||||
8 | Methyl | 32 | 103 | 0.3 | 28 | 0.4 |
9 | 100 | 527 | 9 | 64 | 0.02 | |
10 | 14 | 57 | 35 | 47 | 0.15 | |
11 | 88 | 471 | 11 | 30 | 37 | |
12 | 118 | 789 | 8 | 14 | 0.91 | |
13 | 23 | 172 | 28 | 50 | 0.6 |
Inhibition of purified recombinant human GLS-1 (GAC isoform) assessed via a dual-coupled enzyme assay. IC50 values are reported as the mean of at least three determinations. Standard deviations and counts are included in the supporting information.
Inhibition of proliferation of A549 cells. IC50 values are reported as the mean of at least three determinations. Standard deviations and counts are included in the supporting information.
Liver microsomal intrinsic clearance (mL/min/kg protein).
Kinetic aqueous solubility (μM) in phosphate buffer (100 mM) at pH 7.4; shaken for 1 hour at RT.